Independent analysis puts a MKM dulaglutide lot at 99.2%, against 96.7% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 74 of 170 of this archive, newest first.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Insulin syringes are graduated in units on a convention that fixes 100 units to one millilitre. That convention says nothing about how much peptide is in a unit, and…
A market that competes on one measurement will optimise that measurement. There are legitimate ways to raise a purity figure that involve no change to the product at all.
The result is unremarkable. What the report omits is not.
Follow the resin, not the catalogue.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The supplier has not disputed the finding. It has not explained the gap either.
A withdrawal trial answers a narrower question than it appears to. This piece states which question.
Deamidation, oxidation, aggregation and hydrolysis account for nearly all of what happens to a peptide over time. Each has a characteristic residue, a characteristic…
The result is unremarkable. What the report omits is not.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The document is four pages. Three of them are about dates.
A proper account of an operation that existed, and of what closing it cost.
A retest date says that material should be re-examined before use. An expiry date says it should not be used. The trade uses the second word for the first concept.
What would be needed to catch each of these, and what it would cost.
The four-week step exists because four to five weeks is approximately how long a once-weekly drug takes to stop rising at a fixed dose. That is a good reason, and it is not…
The supplier has not disputed the finding. It has not explained the gap either.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
The observation that closes a facility is rarely the dramatic one.
Every major phase 3 protocol in this class allowed escalation to be delayed for tolerability. Almost no product label explains the mechanics of doing so.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
Every degradation pathway accelerates by orders of magnitude on reconstitution, because the solvent that lyophilisation removed is the reagent most of them need.
Reported from the sessions, and from the two hours afterwards.
Reported from the analysis, not from a warning notice.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.